Juan Caballería

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Vlad Ratziu, Stephen A. Harrison, Sven Francque et al. · Gastroenterology · 2016 · 1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease

Yi Duan, Cristina Llorente, Sonja Lang et al. · Nature · 2019 · 821 citations · Full text

Life Sciences, Immunology, Microbiology +16

A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis

Scott L. Friedman, Vlad Ratziu, Stephen A. Harrison et al. · Hepatology · 2017 · 658 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis

Francisca G. Caballero, Anna Colell, Albert Morales et al. · Cell Metabolism · 2006 · 603 citations · Full text

Life Sciences, Biochemistry, Cell Biology +14

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12